CCL3 (MIP-1α) plasma levels and the risk for disease progression in chronic lymphocytic leukemia

B-cell receptor (BCR) signaling has been inferred as an important mechanism for disease progression in chronic lymphocytic leukemia (CLL) and other B-cell malignancies. In response to BCR activation, CLL cells secrete the chemokine CCL3, which fosters interactions between CLL cells and the leukemia...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Sivina, Mariela, Hartmann, Elena, Kipps, Thomas J., Rassenti, Laura, Krupnik, Diana, Lerner, Susan, LaPushin, Ruth, Xiao, Lianchun, Huang, Xuelin, Werner, Lillian, Neuberg, Donna, Kantarjian, Hagop, O'Brien, Susan, Wierda, William G., Keating, Michael J., Rosenwald, Andreas, Burger, Jan A.
Format: Artigo
Langue:Inglês
Publié: American Society of Hematology 2011
Sujets:
Lymphoid Neoplasia
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3318778/
https://ncbi.nlm.nih.gov/pubmed/21115978
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2010-09-307249
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires